Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aravind Arepally

Vascular & Interventional Radiology Atlanta, GA Medical Doctor

NPI 1275597130 CMS profile 57523

1968 Peachtree Rd Nw, Attn: Radiology Department, Atlanta, GA 30309

Open in the dashboard

General payments

$248,702

166 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Aravind Arepally of Atlanta, GA is reported in the CMS Open Payments database as having received $248,702 across 166 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $839 9
2024 General $1,444 21
2023 General $8,151 30
2022 General $37,683 16
2021 General $17,430 15
2020 General $36,612 19
2019 General $146,544 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aravind Arepally
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Aravind Arepally were reported at $839. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Aravind Arepally Vascular & Interventional Radiology median Middle half National median
2019 $146,544 $422 $125–$1,555 $163
2020 $36,612 $200 $68–$652 $114
2021 $17,430 $280 $99–$866 $132
2022 $37,683 $433 $137–$1,497 $149
2023 $8,151 $506 $152–$2,019 $160
2024 $1,444 $556 $175–$1,930 $164
2025 $839 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Surefire Medical, Inc. $154,541 51 payments
  2. Siemens Medical Solutions USA, Inc. $47,634 11 payments
  3. Biocompatibles, Inc. $18,739 16 payments
  4. W. L. Gore & Associates, Inc. $15,235 46 payments
  5. Varian Medical Systems, Inc. $8,640 3 payments
  6. Boston Scientific Corporation $1,345 16 payments
  7. Delcath Systems $1,131 8 payments
  8. Medtronic, Inc. $329 3 payments
  9. Sirtex Medical Inc $169 3 payments
  10. BTG International Canada Inc. $149 1 payment
  11. Other $790 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $209,900 44 payments
  2. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $14,260 2 payments
  3. Travel and Lodging $10,697 19 payments
  4. Honoraria $6,380 2 payments
  5. Food and Beverage $6,265 98 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,200 1 payment
Products named General payments · program years 2019–2025
  1. Precision Infusion System $153,591 43 payments
  2. THERASPHERE - BIO $18,256 8 payments
  3. Embozene $13,031 5 payments
  4. VIATORR Endoprosthesis $10,109 11 payments
  5. GORE VIABAHN Endoprosthesis $6,840 10 payments
  6. Radiation Oncology $4,960 1 payment
  7. VIATORR TIPS Endoprosthesis $3,810 3 payments
  8. BrachyVision $1,200 1 payment
  9. Hepzato Kit $1,131 8 payments
  10. TRINAV INFUSION SYSTEM $950 8 payments
  11. Other $4,355 70 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 146 billing codes

Paid by Medicare

$31,830

Medicare's payments for the services billed

Medicare patients

653

Average age 73

Services billed

915

335 women, 318 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Ischemic heart disease 48%
Chronic kidney disease 41%
Diabetes 39%
Heart failure 38%
Atrial fibrillation 34%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Hepzato Kit
  • Delcath Systems $750
$750 — —
XIFAXAN
  • Salix Pharmaceuticals, a division of Bausch Health US, LLC $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

166 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record